{"domain":"adocia.com","status":"valid","tier":"listed","authority":47,"verified":false,"title":"Adocia","summary":null,"country":"FR","country_source":"ip","publisher_country":null,"publisher_country_source":null,"hosting_country":"FR","llms_txt":"https://adocia.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-21T23:40:41.094Z","agent_terms":null,"categories":["healthcare","science-research"],"capabilities":[],"inferred_tags":["biotechnology","diabetes","obesity","long-acting drugs","adoxlong"],"audience":"mixed","agent_uses":["search_content"],"language":"en","platform_generated":false,"agent_summary":"Adocia, clinical-stage biotech developing long-acting treatments for diabetes and obesity, with its AdoXLong technology platform and news/publications.","llms_txt_cached":"https://agentwebmap.com/v1/domain/adocia.com/llms.txt","agentic":"informational","section_keys":["categories","general-meeting","medias-and-publications","pages","posts","products","regulated-information","reusable-blocks","sitemaps","technology-platforms"],"section_partial":false,"section_indexed_at":"2026-10-21T23:40:44.319Z"}